Post by Amsterdam Chemistry Network (ACN)

WEEKLY NEWS #acnweekly 🔬 📰 👀 1) Eli Lilly and Company to acquire three vaccine developers (Curevo Vaccine, LimmaTech Biologics AG and Vaccine Company) in deals worth up to $ 3.8B. 2) Liminatus Pharma, Inc agreed to buy CAR-T biotech InnocsAI in a stock deal valued at $320M. 3) Regeneron signed a $2.3B pact with Parabilis Medicines to develop new antibody-drug conjugate approaches. 4) Amsterdam UMC researchers show soccer heading triggers temporary elevations in biomarkers of neural damage. 5) Apogee Therapeutics bags $1.3B Blackstone deal to advance into the phase 3 clinical trial for their eczema challenger. 6) Bristol Myers Squibb goes all in on Anthropic’s Claude adoption, weighs the potential for Claude to accelerate the drug discovery program. 7) GSK's Hepatitis B shot delivers a functional cure for one in five, a leap past today's 1% standard. 8) Matisse Pharmaceuticals B.V. receives FDA clearance to start phase 2 clinical trial for sepsis treatment. 9) Kordata Dynamics launches with neural-focused AI clinical trial model. 10) Olympus Corporation to acquire BioProtect to expand its portfolio of urological technologies and address prostate cancer.   #ACNWeekly #Biotech #LifeSciences #PharmaNews #AIBiotech #BiotechDeals #Oncology #GeneTherapy #HealthInnovation #FutureOfMedicine Links 🔎🔎🔎 1.     https://lnkd.in/eUpMqEXr 2.     https://lnkd.in/edztG54D 3.     https://lnkd.in/g8HYi6uq 4.     https://lnkd.in/eqR9WbCW 5.     https://lnkd.in/ehwFU6aW 6.     https://lnkd.in/e9E7_TzH 7.     https://lnkd.in/ekgFHaFf 8.     https://lnkd.in/ecS67BuV 9.     https://lnkd.in/ee-dAmYw https://lnkd.in/gac-8uPN